ENLIE Pharmaceutical JSC (HSTC:BCP) EV-to-EBITDA: (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:BCP ENLIE Pharmaceutical JSC HSTC:BCP
25 GF Score
Price ₫10,600.00
View Full Analysis

What is ENLIE Pharmaceutical JSC EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, ENLIE Pharmaceutical JSC's enterprise value is ₫0.00 Mil. ENLIE Pharmaceutical JSC does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate ENLIE Pharmaceutical JSC's EV-to-EBITDA at this moment.

The historical rank and industry rank for ENLIE Pharmaceutical JSC's EV-to-EBITDA or its related term are showing as below:

HSTC:BCP's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.94
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-07-28), ENLIE Pharmaceutical JSC's stock price is ₫10600.00. ENLIE Pharmaceutical JSC does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate ENLIE Pharmaceutical JSC's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

ENLIE Pharmaceutical JSC  (HSTC:BCP) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

ENLIE Pharmaceutical JSC's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10600.00/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

ENLIE Pharmaceutical JSC EV-to-EBITDA Related Terms

ENLIE Pharmaceutical JSC EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for ENLIE Pharmaceutical JSC's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENLIE Pharmaceutical JSC EV-to-EBITDA Chart

ENLIE Pharmaceutical JSC Annual Data
Trend
EV-to-EBITDA

ENLIE Pharmaceutical JSC Semi-Annual Data
EV-to-EBITDA

HSTC:BCP vs : EV-to-EBITDA Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ENLIE Pharmaceutical JSC's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ENLIE Pharmaceutical JSC EV-to-EBITDA vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ENLIE Pharmaceutical JSC's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where ENLIE Pharmaceutical JSC's EV-to-EBITDA falls into.


HSTC:BCP
25GF Score
ENLIE Pharmaceutical JSC HSTC:BCP
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENLIE Pharmaceutical JSC EV-to-EBITDA Calculation

ENLIE Pharmaceutical JSC's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/
=

ENLIE Pharmaceutical JSC Business Description

Comparable Companies
Address NA6 Street, My Phuoc 2 Industrial Park, Ben Cat district, Binh Duong, VNM
ENLIE Pharmaceutical JSC is engaged in the production and trading of pharmaceuticals, medical supplies, cosmetics, foods, and functional foods. It is also engaged in the wholesale of other installation materials and equipment in the construction.
25GF Score

Get the complete analysis for HSTC:BCP

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫10,600.00
Price